Becker's Healthcare July 26, 2024
Ozempic and other GLP-1 medications are increasingly affecting hospital operations and the U.S. healthcare industry.
Here are seven updates on the popular drug class, listed by publishing date in Becker’s:
1. Experts who study the illegal drug supply market told The New York Times they are worried about the rising demand for GLP-1 medications from counterfeit sources.
The National Association of Boards of Pharmacy has identified thousands of websites selling counterfeit GLP-1 medications, and the FDA has seized thousands of fake Ozempic units. Drugmakers have filed lawsuits against companies allegedly selling unapproved products, but the market seems to be growing for “faux-zempic.”
2. Researchers at Oxford University in England found a potential link between semaglutide (Ozempic, Wegovy...
Today's Sponsors
Today's Sponsor